Cagrilintide Side Effects: What Studies and Users Report
What FDA labels, clinical studies and people who use Cagrilintide report, how strong that evidence is, and what is still unknown.
Side effects reported in studies
Side effects reported in published studies, strongest design first. Frequencies are quoted as the source gives them; animal results are labelled.
| Side effect | How common | Study type | Source |
|---|---|---|---|
| Nausea | 4 of 30 on cagrilintide 2.4 mg alone; 9 of 31 on cagrilintide plus semaglutide; 5 of 31 on semaglutide alone | Human RCTn = 92 | ClinicalTrials.gov NCT04982575 |
| Constipation | 4 of 30 on cagrilintide 2.4 mg alone; 5 of 31 on cagrilintide plus semaglutide; 4 of 31 on semaglutide alone | Human RCTn = 92 | ClinicalTrials.gov NCT04982575 |
| Headache | 3 of 30 on cagrilintide 2.4 mg alone; 0 of 31 on cagrilintide plus semaglutide; 3 of 31 on semaglutide alone | Human RCTn = 92 | ClinicalTrials.gov NCT04982575 |
| Diarrhoea | 2 of 30 on cagrilintide 2.4 mg alone; 5 of 31 on cagrilintide plus semaglutide; 2 of 31 on semaglutide alone | Human RCTn = 92 | ClinicalTrials.gov NCT04982575 |
| Injection site reaction | 2 of 30 on cagrilintide 2.4 mg alone; 1 of 31 on cagrilintide plus semaglutide; 0 of 31 on semaglutide alone | Human RCTn = 92 | ClinicalTrials.gov NCT04982575 |
| Gastrointestinal adverse events | most common (mild or moderate); adverse events in 24 (80%) of the cagrilintide group | Human RCTn = 92 | Lancet 2023, PMID 37364590 |
| Gastrointestinal events and nausea | 41%-63% vs 32% with placebo; nausea 20%-47% vs 18% | Human RCT | Lancet 2021, PMID 34798060 |
| Nausea | 20 of 101 on cagrilintide 0.3 mg; 27 of 100 on cagrilintide 0.6 mg; 37 of 102 on cagrilintide 1.2 mg; 32 of 102 on cagrilintide 2.4 mg; 47 of 101 on cagrilintide 4.5 mg; 39 of 99 on liraglutide 3.0 mg; 18 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Vomiting | 6 of 101 on cagrilintide 0.3 mg; 6 of 100 on cagrilintide 0.6 mg; 5 of 102 on cagrilintide 1.2 mg; 9 of 102 on cagrilintide 2.4 mg; 8 of 101 on cagrilintide 4.5 mg; 20 of 99 on liraglutide 3.0 mg; 3 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Constipation | 11 of 101 on cagrilintide 0.3 mg; 9 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 17 of 102 on cagrilintide 2.4 mg; 21 of 101 on cagrilintide 4.5 mg; 26 of 99 on liraglutide 3.0 mg; 7 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Diarrhoea | 15 of 101 on cagrilintide 0.3 mg; 10 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 18 of 102 on cagrilintide 2.4 mg; 7 of 101 on cagrilintide 4.5 mg; 18 of 99 on liraglutide 3.0 mg; 9 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Injection site reaction | 4 of 101 on cagrilintide 0.3 mg; 4 of 100 on cagrilintide 0.6 mg; 7 of 102 on cagrilintide 1.2 mg; 12 of 102 on cagrilintide 2.4 mg; 10 of 101 on cagrilintide 4.5 mg; 1 of 99 on liraglutide 3.0 mg; 0 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Decreased appetite | 4 of 101 on cagrilintide 0.3 mg; 9 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 13 of 102 on cagrilintide 2.4 mg; 17 of 101 on cagrilintide 4.5 mg; 9 of 99 on liraglutide 3.0 mg; 4 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Dyspepsia | 3 of 101 on cagrilintide 0.3 mg; 2 of 100 on cagrilintide 0.6 mg; 3 of 102 on cagrilintide 1.2 mg; 3 of 102 on cagrilintide 2.4 mg; 4 of 101 on cagrilintide 4.5 mg; 10 of 99 on liraglutide 3.0 mg; 4 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Headache | 10 of 101 on cagrilintide 0.3 mg; 5 of 100 on cagrilintide 0.6 mg; 11 of 102 on cagrilintide 1.2 mg; 11 of 102 on cagrilintide 2.4 mg; 7 of 101 on cagrilintide 4.5 mg; 13 of 99 on liraglutide 3.0 mg; 12 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Dizziness | 8 of 101 on cagrilintide 0.3 mg; 2 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 9 of 102 on cagrilintide 2.4 mg; 9 of 101 on cagrilintide 4.5 mg; 5 of 99 on liraglutide 3.0 mg; 3 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Fatigue | 8 of 101 on cagrilintide 0.3 mg; 5 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 10 of 102 on cagrilintide 2.4 mg; 20 of 101 on cagrilintide 4.5 mg; 8 of 99 on liraglutide 3.0 mg; 3 of 101 on placebo | Human RCT | ClinicalTrials.gov NCT03856047 |
| Administration-site reactions | among the most frequent adverse events (no figure in abstract) | Human RCT | Lancet 2021, PMID 34798060 |
| Adverse events leading to discontinuation | 30 participants (4%) | Human RCT | Lancet 2021, PMID 34798060 |
| Adverse events (combined with semaglutide)“Most adverse events were mild to moderate in severity and the proportion of participants with one or more adverse event was similar across treatment groups.” | Frequency not stated | Human RCTn = 96 | Lancet 2021, PMID 33894838 |
| Gastrointestinal disorders (with semaglutide 2.4 mg) | 207 of 566 adverse events (37%) | Human RCTn = 96 | Lancet 2021, PMID 33894838 |
Overall safety findings
What studies said about safety as a whole, without naming a specific effect.
| Finding | How common | Study type | Source |
|---|---|---|---|
| No serious adverse events in impairment studies“In both studies, no serious TEAEs, TEAEs leading to study withdrawal or deaths were reported.” | Frequency not stated | Human controlled trial | Clinical pharmacokinetics 2026, PMID 42228334 |
What users report
Side effects people describe from their own use of Cagrilintide, quoted from 46 Reddit threads we read in r/Peptides and r/Retatrutide (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.
| What people noticed | People reporting it | In their words |
|---|---|---|
| Tiredness or lethargy | 28 | “My first injection I was extremely tired. I’ve never experienced that with tirz.” r/Peptides, Sep 2024“I found cagri absolutely exhausting. I haven’t found tirz or Reta to be that way.” r/Retatrutide, Oct 2025 |
| Nausea | 10 | “Cagri 0.25mg gave me instant nausea but only for the first 2h.” r/Peptides, Jul 2026“Cagri starting dose is .25mg, even that made me nausea.” r/Retatrutide, Feb 2025 |
| Low mood or emotional flatness | 7 | “At first it made me feel emotionally flatlined and borderline depressed” r/Retatrutide, Dec 2025“Also gave me anhendonia” r/Retatrutide, Feb 2025 |
| Constipation | 6 | “I have never been prone to constipation, even with SEMA but happened w Cagri so badly that I will never take it again.” r/Peptides, Nov 2024“it constipated me so bad, it scared me.” r/Retatrutide, Jun 2025 |
| Vomiting | 4 | “swallowing my omegas made me puke” r/Peptides, Jul 2026“Anything I managed to get down instantly came back up.” r/Peptides, Jul 2026Also taking other compounds |
| Headache | 3 | “i get a headache the following day. For the whole day.” r/Peptides, Aug 2024Also taking other compounds“a headache sometimes on the day of shot” r/Peptides, Sep 2024Also taking other compounds |
| Muscle or joint aches | 2 | “I got muscle aches and lost all of my appetite.” r/Retatrutide, Feb 2025“severe fatigue and muscle aches.” r/Retatrutide, Feb 2026Also taking other compounds |
| Bloating or stomach heaviness | 2 | “Cagri makes me feel full, almost bloated sometimes” r/Peptides, Sep 2024Also taking other compounds“It felt like my stomach was frozen with rocks in it.” r/Peptides, Sep 2024Also taking other compounds |
| Feeling cold | 1 | “I was so COLD.” r/Retatrutide, Feb 2025Also taking other compounds |
| Vivid dreams | 1 | “I had such vivid dreams that I was not resting” r/Retatrutide, Feb 2025Also taking other compounds |
| Trouble sleeping | 1 | “I added cag tuesday and I’m back up at 3am” r/Peptides, Oct 2025Also taking other compounds |
| Low libido | 1 | “Killed my sex drive.” r/Peptides, Aug 2024 |
| Lower back pain | 1 | “really intense low back pain for the first 2 days” r/Retatrutide, Sep 2024Also taking other compounds |
5 people in the same threads said they noticed no side effects:
A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.
What is not known
- How common each effect is at the doses people use outside of studies.
- Effects that take longer to appear than the length of the published studies.
- How Cagrilintide interacts with other medicines and supplements.
- Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.
When to get medical help
This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.
The phase 2 dose-finding trial
Permanent stops were similar across groups and mostly due to adverse events.[2]
Gastrointestinal events, especially nausea, were more common than on placebo across the tested range.[2]
Excess over placebo in percentage points across the cagrilintide dose range: gastrointestinal events 9 to 31, nausea 2 to 29.
Calculated from gi 41, 63; gi placebo 32; nausea 20, 47; nausea placebo 18. Formula: range ends minus placebo %
Administration-site reactions are named alongside stomach complaints.[2]
Heart rhythm, kidney and liver impairment, and the semaglutide combination
A thorough QT study reported that cagrilintide did not result in clinically relevant QTcF prolongation.[19]
In studies in renal and hepatic impairment, no serious treatment-emergent adverse events, withdrawals from adverse events, or deaths were reported.[1]
When added to semaglutide, most adverse events were mild to moderate and similar across arms.[3]
Common questions
What are the side effects of cagrilintide?
Gastrointestinal events, mostly nausea, and administration-site reactions were the most frequent in the dose-finding trial.[2]
What side effects do people who use Cagrilintide report?
In the 46 Reddit threads we read (11 Oct 2026), people most often described tiredness or lethargy (28 people), nausea (10 people), low mood or emotional flatness (7 people). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.
Is cagrilintide safe?
Early trials describe it as well tolerated, and a QT study found no relevant effect. It has no approved label of its own in the cached sources.[2]
Is Cagrilintide banned in sport?
Yes. Prohibited by WADA (S0). Tested athletes should not use it.
Does cagrilintide cause nausea?
Yes, more than placebo in the phase 2 trial. Nausea was 20% to 47% across doses versus 18% on placebo.[2]
More on Cagrilintide
Sources
- 1Renal or Hepatic Impairment Does Not Affect Pharmacokinetics, Safety, or Tolerability of Subcutaneous Cagrilintide.Clinical pharmacokinetics · 2026PMID 42228334Accessed 2 Oct 2026
- 2Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.Lancet (London, England) · 2021PMID 34798060Accessed 2 Oct 2026
- 3Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.Lancet (London, England) · 2021PMID 33894838Accessed 2 Oct 2026
- 4Efficacy and Safety of Co-administration of Cagrilintide s.c. 2.4 mg and Semaglutide s.c. 2.4 mg Once Weekly in Subjects With Type 2 DiabetesClinicalTrials.gov (U.S. National Library of Medicine) · 2021clinicaltrials.govAccessed 2 Oct 2026
- 5Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.Lancet (London, England) · 2023PMID 37364590Accessed 11 Oct 2026
- 6Investigation of Safety and Efficacy of NNC0174-0833 for Weight Management - a Dose Finding Trial.ClinicalTrials.gov (U.S. National Library of Medicine) · 2019clinicaltrials.govAccessed 2 Oct 2026
- 7Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 8Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 9Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 10Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 11Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 12Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 13Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 14Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 15Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 16Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 17Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 18Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 19Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.Diabetes, obesity & metabolism · 2024PMID 39279639Accessed 2 Oct 2026
Found an error? Report a correction.